HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Market News Stocks News ETF News Crypto News

4D Molecular Therapeutics, Inc.

Contributing Author

Recent Articles by 4D Molecular Therapeutics, Inc.

Dec-17
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease FDMT GlobeNewswire
Dec-12
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Dec-08
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference FDMT GlobeNewswire
Nov-20
4DMT to Participate in 8th Annual Evercore Healthcare Conference FDMT GlobeNewswire
Nov-17
4DMT Appoints Kristian Humer as Chief Financial Officer FDMT GlobeNewswire
Nov-14
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Nov-10
4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones FDMT GlobeNewswire
Nov-06
4DMT to Participate in Jefferies 2025 London Healthcare Conference FDMT GlobeNewswire
Nov-06
4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants FDMT GlobeNewswire
Nov-06
4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150's Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years FDMT GlobeNewswire
Oct-30
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific FDMT GlobeNewswire
Oct-17
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Oct-14
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference FDMT GlobeNewswire
Oct-13
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation FDMT GlobeNewswire
Sep-12
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Sep-02
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness FDMT GlobeNewswire
Aug-25
4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
Aug-15
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Aug-11
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones FDMT GlobeNewswire
Aug-06
4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference FDMT GlobeNewswire
Jul-31
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update FDMT GlobeNewswire
Jul-24
4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists FDMT GlobeNewswire
Jul-11
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
Jul-02
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution FDMT GlobeNewswire
May-28
4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
May-16
4DMT Announces New Employment Inducement Grants FDMT GlobeNewswire
May-08
4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones FDMT GlobeNewswire
May-05
4DMT to Participate in Upcoming Investor Conferences FDMT GlobeNewswire
May-01
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME FDMT GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.